SG11201606856SA - Modulation of cell growth and glycosylation in recombinant glycoprotein production - Google Patents

Modulation of cell growth and glycosylation in recombinant glycoprotein production

Info

Publication number
SG11201606856SA
SG11201606856SA SG11201606856SA SG11201606856SA SG11201606856SA SG 11201606856S A SG11201606856S A SG 11201606856SA SG 11201606856S A SG11201606856S A SG 11201606856SA SG 11201606856S A SG11201606856S A SG 11201606856SA SG 11201606856S A SG11201606856S A SG 11201606856SA
Authority
SG
Singapore
Prior art keywords
glycosylation
modulation
cell growth
recombinant glycoprotein
glycoprotein production
Prior art date
Application number
SG11201606856SA
Inventor
Oliver Popp
Nicola Beaucamp
Georg Drabner
Stephanie Esslinger
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50184787&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG11201606856S(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SG11201606856SA publication Critical patent/SG11201606856SA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/38—Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/40—Immunoglobulins specific features characterized by post-translational modification
    • C07K2317/41—Glycosylation, sialylation, or fucosylation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SG11201606856SA 2014-02-27 2015-02-24 Modulation of cell growth and glycosylation in recombinant glycoprotein production SG11201606856SA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14157030 2014-02-27
PCT/EP2015/053804 WO2015128314A1 (en) 2014-02-27 2015-02-24 Modulation of cell growth and glycosylation in recombinant glycoprotein production

Publications (1)

Publication Number Publication Date
SG11201606856SA true SG11201606856SA (en) 2016-09-29

Family

ID=50184787

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201606856SA SG11201606856SA (en) 2014-02-27 2015-02-24 Modulation of cell growth and glycosylation in recombinant glycoprotein production

Country Status (20)

Country Link
US (3) US20170058309A1 (en)
EP (1) EP3110961B1 (en)
JP (2) JP6831702B2 (en)
KR (1) KR102280638B1 (en)
CN (1) CN106133146B (en)
BR (1) BR112016017660B1 (en)
CA (1) CA2937611C (en)
DK (1) DK3110961T3 (en)
ES (1) ES2769003T3 (en)
HR (1) HRP20200100T1 (en)
HU (1) HUE047575T2 (en)
LT (1) LT3110961T (en)
MX (1) MX369395B (en)
PL (1) PL3110961T3 (en)
PT (1) PT3110961T (en)
RS (1) RS59881B1 (en)
RU (1) RU2712562C2 (en)
SG (1) SG11201606856SA (en)
SI (1) SI3110961T1 (en)
WO (1) WO2015128314A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101952220B1 (en) 2011-11-21 2019-05-27 이노베이션 해머 엘엘씨 Methods and systems for growing plants using silicate-based substrates, cultivation of enhanced photosynthetic productivity and photosafening by utilization of exogenous glycopyranosides for endogenous glycopyranosyl-protein derivatives, and formulations, processes and systems for the same
HUE047575T2 (en) * 2014-02-27 2020-04-28 Hoffmann La Roche Modulation of cell growth and glycosylation in recombinant glycoprotein production
ES2784503T3 (en) * 2014-12-01 2020-09-28 Amgen Inc Procedure for manipulating the level of glycan content of a glycoprotein
WO2017189311A1 (en) 2016-04-29 2017-11-02 Innovation Hammer Llc Formulations and methods for treating photosynthetic organisms and enhancing qualities and quantities of yields with glycan composite formulations
WO2019077628A1 (en) * 2017-10-16 2019-04-25 Council Of Scientific & Industrial Research Zinc supplementation for decreasing galactosylation of recombinant glycoproteins
IL313983A (en) * 2018-03-26 2024-08-01 Amgen Inc Total afucosylated glycoforms of antibodies produced in cell culture
US20210147532A1 (en) * 2018-05-24 2021-05-20 Ares Trading S.A. Method for controlling the afucosylation level of a glycoprotein composition
HU231514B1 (en) 2018-11-07 2024-07-28 Richter Gedeon Nyrt. Method for modifying the glycosylation profile of a recombinant glycoprotein produced in cell culture
MA54248A (en) * 2018-11-13 2021-09-22 Janssen Biotech Inc REGULATION OF TRACE METALS DURING ANTI-CD38 ANTIBODY PRODUCTION
JP2020188737A (en) * 2019-05-23 2020-11-26 東ソー株式会社 Production method of antibody with improved antibody dependent cell mediated cytotoxicity activity

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4767704A (en) 1983-10-07 1988-08-30 Columbia University In The City Of New York Protein-free culture medium
IL87737A (en) 1987-09-11 1993-08-18 Genentech Inc Method for culturing polypeptide factor dependent vertebrate recombinant cells
US5705364A (en) * 1995-06-06 1998-01-06 Genentech, Inc. Mammalian cell culture process
US6030945A (en) 1996-01-09 2000-02-29 Genentech, Inc. Apo-2 ligand
JP2000517188A (en) 1996-08-30 2000-12-26 ライフ テクノロジーズ，インコーポレイテッド Serum-free mammalian cell culture medium and uses thereof
WO1999061650A1 (en) * 1998-05-29 1999-12-02 Genentech, Inc. Cell culture process for producing glycoproteins
JP2001120262A (en) * 1999-10-26 2001-05-08 Welfide Corp Method for enhancing production of physiologically active substance
CA2438148A1 (en) 2001-02-15 2002-08-29 Centocor, Inc. Chemically defined medium for cultured mammalian cells
US20050287666A1 (en) * 2004-06-29 2005-12-29 Invitrogen Corporation Cell culture medium comprising transition metals or trace elements
US7294484B2 (en) 2004-08-27 2007-11-13 Wyeth Research Ireland Limited Production of polypeptides
RS51913B (en) 2004-11-02 2012-02-29 Ares Trading S.A. Serum-free cell culture medium for mammalian cells
US20070231895A1 (en) 2005-11-02 2007-10-04 Lee Gene W Methods for adapting mammalian cells
EP4155385A1 (en) 2005-12-08 2023-03-29 Amgen Inc. Improved production of glycoproteins using manganese
PT2495307T (en) * 2006-07-13 2018-05-10 Wyeth Llc Production of coagulation factor ix with improved glycosylation pattern
EP2395077A1 (en) 2006-11-03 2011-12-14 Wyeth LLC Glycolysis-inhibiting substances in cell culture
AU2008223133A1 (en) 2007-03-02 2008-09-12 Wyeth Use of copper and glutamate in cell culture for production of polypeptides
US20110053223A1 (en) * 2009-08-14 2011-03-03 Robert Bayer Cell culture methods to make antibodies with enhanced adcc function
EP2531592A1 (en) * 2010-02-04 2012-12-12 Vivalis Fed-batch process using concentrated cell culture medium for the efficient production of biologics in eb66 cells
AU2011246502B2 (en) 2010-04-26 2014-08-28 Novartis Ag Improved cell cultivation process
WO2012149197A2 (en) 2011-04-27 2012-11-01 Abbott Laboratories Methods for controlling the galactosylation profile of recombinantly-expressed proteins
CN105189735B (en) 2011-04-29 2019-04-12 拜康研究有限公司 The method of lactic acid build and the method for production polypeptide are reduced in the training period
EP2809773B1 (en) 2012-01-30 2020-09-02 Dr. Reddy's Laboratories Limited Process of modulating man5 and/or afucosylation content of glycoprotein composition
US9598667B2 (en) 2013-10-04 2017-03-21 Abbvie Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
HUE047575T2 (en) * 2014-02-27 2020-04-28 Hoffmann La Roche Modulation of cell growth and glycosylation in recombinant glycoprotein production

Also Published As

Publication number Publication date
HRP20200100T1 (en) 2020-04-03
KR102280638B1 (en) 2021-07-22
WO2015128314A1 (en) 2015-09-03
HUE047575T2 (en) 2020-04-28
CA2937611C (en) 2023-01-03
RU2016138176A (en) 2018-03-29
US20210222220A1 (en) 2021-07-22
PT3110961T (en) 2020-01-29
JP6934507B2 (en) 2021-09-15
JP2020054351A (en) 2020-04-09
SI3110961T1 (en) 2020-03-31
EP3110961B1 (en) 2019-11-27
US20240327890A1 (en) 2024-10-03
CA2937611A1 (en) 2015-09-03
JP2017506515A (en) 2017-03-09
DK3110961T3 (en) 2020-02-03
LT3110961T (en) 2020-02-10
EP3110961A1 (en) 2017-01-04
RS59881B1 (en) 2020-03-31
US20170058309A1 (en) 2017-03-02
BR112016017660A2 (en) 2017-08-08
KR20160125514A (en) 2016-10-31
RU2712562C2 (en) 2020-01-29
PL3110961T3 (en) 2020-04-30
CN106133146B (en) 2021-05-04
JP6831702B2 (en) 2021-02-17
MX2016010236A (en) 2016-10-13
RU2016138176A3 (en) 2018-10-29
BR112016017660B1 (en) 2022-04-19
CN106133146A (en) 2016-11-16
MX369395B (en) 2019-11-07
ES2769003T3 (en) 2020-06-24

Similar Documents

Publication Publication Date Title
SG11201606856SA (en) Modulation of cell growth and glycosylation in recombinant glycoprotein production
HK1252582A1 (en) Modified natural killer cells and natural killer cell lines having increased cytotoxicity
IL253248A0 (en) Natural killer cells and uses thereof
IL258666A (en) Natural killer cells and ilc3 cells and uses thereof
SG11201609118RA (en) Modified natural killer cells and uses thereof
ZA201605308B (en) Plant growth promoting rhizobacterial strains and their uses
ZA201704595B (en) Methods of producing long acting ctp-modified growth hormone polypeptides
IL263779A (en) Protein production in plant cells
HK1223980A1 (en) Improved recombinant polypeptide production methods
HK1245297A1 (en) Methods of improving yield in recombinant protein production
DK3242935T3 (en) O-GLYCANSIALYLATED RECOMBINANT GLYCOPROTEINS AND CELL LINES FOR THEIR PRODUCTION
HK1220492A1 (en) Recombinant polypeptide production
IL247776A0 (en) Methods for producing recombinant glycoproteins with modified glycosylation
IL250530B (en) Production of fully processed and functional factor x in a furin-secreting mammalian expression system
EP3322429B8 (en) Growth promoting peptides and uses thereof
SI3289088T1 (en) Uncoupling growth and protein production
ZA201700867B (en) Modifying protein production in plants
HK1220991A1 (en) Formulations and methods for increased recombinant protein production
PL3158055T3 (en) Improved production of recombinant von willebrand factor in a bioreactor
IL258193A (en) Modified natural killer cells having anti-fugetactic properties and uses thereof
GB201308120D0 (en) Recombinant protein and method for its production
GB201308218D0 (en) Chlor-Alkali Process and Plant
DE112015003749A5 (en) PEPTIDE FOR USE IN REDUCING SIDE EFFECTS IN THE FORM OF IMMUNOSTIMULATORY REACTIONS / EFFECTS